Format

Send to

Choose Destination
J Cell Biochem. 2018 Jul;119(7):5016-5027. doi: 10.1002/jcb.26580. Epub 2018 Feb 27.

Leptin: A new therapeutic target for treatment of diabetes mellitus.

Author information

1
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan.
2
Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan.

Abstract

Leptin is an endogenous protein having 167 amino acids and is derived from adipocytes. It has tertiary structure that resembles with that of the pro-inflammatory cytokines family. The fundamental role of leptin is to maintain the energy homeostasis with the aid of its counter hormone called ghrelin, known as the "hunger hormone." Small quantities of leptin are also present in various tissues like ovary, placenta, pituitary gland, mammary gland, skeletal muscle, stomach, and lymphoid tissue. Expression of leptin is strongly associated with various inflammatory responses and immune system, and plays crucial role in the pathophysiology of obesity and development of diabetes mellitus (DM) and insulin resistance. The metabolic action of leptin is equally important as that of insulin in the pathophysiology of obesity and DM. Thereby, this review article tends to discuss the diverse and complicated role of leptin in the pathogenesis of DM. Furthermore, this article will highlight the signifying role of leptin as a therapeutic target by indicating the targeted treatment of DM through the appropriate understanding of advanced therapeutic approaches using leptin as a treatment strategy for DM.

KEYWORDS:

diabetes mellitus; ghrelin; leptin; obesity; targeted treatment

PMID:
29236298
DOI:
10.1002/jcb.26580
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center